Atlas Trials

Bioequivalence Study of Bafiertam 190 mg and Vumerity® 462 mg Delayed-Release Capsules in Fasting Healthy Subjects

Clinical trial NCT05181215 · COMPLETED

Trial details

NCT number
NCT05181215
Sponsor
Banner Life Sciences LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Relapsing Remitting Multiple Sclerosis
Start date
2021-05-14
Primary completion
2021-08-27
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.